Mid Continent Capital’s Thermo Fisher Scientific TMO Stock Holding History

Mid Continent Capital’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	$41.2M	Sell	336,540 -6,310	-2%	-$822K	2.67%	6
2015 Q2	$44.5M	Buy	342,850 +345	+0.1%	+$45K	2.46%	7
2015 Q1	$46M	Buy	342,505 +10,335	+3%	+$1.33M	2.54%	7
2014 Q4	$41.6M	Buy	332,170 +39,140	+13%	+$4.76M	2.37%	8
2014 Q3	$35.7M	Buy	293,030 +46,940	+19%	+$5.71M	2.07%	10
2014 Q2	$29M	Sell	246,090 -8,345	-3%	-$982K	1.68%	16
2014 Q1	$30.6M	Buy	254,435 +8,620	+4%	+$1.02M	1.84%	15
2013 Q4	$27.4M	Buy	245,815 +705	+0.3%	+$70.1K	1.69%	14
2013 Q3	$22.6M	Buy	245,110 +13,220	+6%	+$1.2M	1.59%	16
2013 Q2	$19.6M	Buy	+231,890	New	+$19.3M	1.43%	19

Other funds holding TMO

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LTI

Laffer Tengler Investments Nashville, Tennessee $782M AUM 33.6% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Mid Continent Capital's TMO Position: Q3 2015 in Review

Mid Continent Capital reduced its Thermo Fisher Scientific (TMO) stake by 1.8% in Q3 2015, selling an estimated $822K and leaving 336,540 shares worth $41.2M. The position accounts for 2.67% of the portfolio, ranked #6.

Mid Continent Capital first reported a position in TMO in Q2 2013 and has held it in 10 quarters since. The position peaked at $46M in Q1 2015. 970 funds tracked by Wall St. Rank hold TMO as of Q3 2015.

Mid Continent Capital held 336,540 shares of Thermo Fisher Scientific worth $41.2M as of Q3 2015.
Mid Continent Capital sold 6,310 Thermo Fisher Scientific shares in Q3 2015, an estimated $822K.
Thermo Fisher Scientific made up 2.67% of Mid Continent Capital's portfolio in Q3 2015, its #6 holding.
Mid Continent Capital first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 10 quarters since.
Mid Continent Capital's Thermo Fisher Scientific position peaked at $46M in Q1 2015.
970 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2015.

Based on Mid Continent Capital's 13F filing for Q3 2015, filed 22 Oct 2015.